171 related articles for article (PubMed ID: 7779147)
1. Studies on the in vitro and in vivo genotoxicity of [2,2-dimethyl-6- (4-chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl]-acetic acid.
Heidemann A; Tries S; Laufer S; Augustin J
Arzneimittelforschung; 1995 Apr; 45(4):486-90. PubMed ID: 7779147
[TBL] [Abstract][Full Text] [Related]
2. Genotoxicity testing of pidotimod in vitro and in vivo.
Adams K; Allen JA; Brooker PC; Henderson L; Jones E; Proudlock RJ; Mailland F; Coppi G
Arzneimittelforschung; 1994 Dec; 44(12A):1454-9. PubMed ID: 7857341
[TBL] [Abstract][Full Text] [Related]
3. Genotoxicity evaluation of sesamin and episesamin.
Hori H; Takayanagi T; Kamada Y; Shimoyoshi S; Ono Y; Kitagawa Y; Shibata H; Nagao M; Fujii W; Sakakibara Y
Mutat Res; 2011 Feb; 719(1-2):21-8. PubMed ID: 20937410
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the mutagenicity of a-dihydroergocryptine in vitro and in vivo.
Adams K; Allen JA; Brooker PC; Jones E; Proudlock RJ; Mailland F; Coppi G
Arzneimittelforschung; 1993 Dec; 43(12):1253-7. PubMed ID: 8141809
[TBL] [Abstract][Full Text] [Related]
5. Toxicology and carcinogenesis studies of p-nitrotoluene (CAS no. 99-99-0) in F344/N rats and B6C3F(1) mice (feed studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2002 May; (498):1-277. PubMed ID: 12118261
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal tolerance of [2,2-dimethyl-6-(4-chlorophenyl-7-phenyl- 2,3-dihydro-1H-pyrrolizine-5-yl]-acetic acid in the rat.
Laufer S; Tries S; Augustin J; Elsässer R; Algate DR; Atterson PR; Munt PL
Arzneimittelforschung; 1994 Dec; 44(12):1329-33. PubMed ID: 7848352
[TBL] [Abstract][Full Text] [Related]
7. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
Irwin RD
Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship of anthracycline-induced genotoxicity in vitro.
Westendorf J; Marquardt H; Marquardt H
Cancer Res; 1984 Dec; 44(12 Pt 1):5599-604. PubMed ID: 6388827
[TBL] [Abstract][Full Text] [Related]
9. Genotoxicity studies on licorice flavonoid oil (LFO).
Nakagawa K; Hidaka T; Kitano M; Asakura M; Kamigaito T; Noguchi T; Hosoe K
Food Chem Toxicol; 2008 Jul; 46(7):2525-32. PubMed ID: 18502556
[TBL] [Abstract][Full Text] [Related]
10. Effects of the mycotoxin ochratoxin A in a bacterial and a mammalian in vitro mutagenicity test system.
Föllmann W; Lucas S
Arch Toxicol; 2003 May; 77(5):298-304. PubMed ID: 12734645
[TBL] [Abstract][Full Text] [Related]
11. [Genotoxicity studies of cefmatilen hydrochloride hydrate (S-1090)].
Kondo K; Takase S; Nishimoto Y; Miyajima H; Shiratori O; Miyake Y
J Toxicol Sci; 2001 May; 26 Suppl 1():243-54. PubMed ID: 11400316
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of chemopreventive agents for genotoxic activity.
Doppalapudi RS; Riccio ES; Rausch LL; Shimon JA; Lee PS; Mortelmans KE; Kapetanovic IM; Crowell JA; Mirsalis JC
Mutat Res; 2007 May; 629(2):148-60. PubMed ID: 17387038
[TBL] [Abstract][Full Text] [Related]
13. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
14. Genotoxicity studies on sertaconazole.
Romero A; Palacín C; Mosesso P; Hodson-Walker G; Marcos R; Batiste-Alentorn M; Villamayor F; Sacristán A; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):743-5. PubMed ID: 1627196
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo assessment of the genotoxic activity of aloesin.
Lynch B; Simon R; Roberts A
Regul Toxicol Pharmacol; 2011 Nov; 61(2):215-21. PubMed ID: 21821088
[TBL] [Abstract][Full Text] [Related]
16. Tumorigenicity in vivo and induction of mutagenesis and DNA repair in vitro by aclacinomycin A and marcellomycin: structure-activity relationship and predictive value of short-term tests.
Westendorf J; Marquardt H; Ketkar MB; Mohr U; Marquardt H
Cancer Res; 1983 Nov; 43(11):5248-51. PubMed ID: 6352017
[TBL] [Abstract][Full Text] [Related]
17. General pharmacology of [2,2-dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3- dihydro-1H-pyrrolizine-5-yl]-acetic acid in experimental animals.
Algate DR; Augustin J; Atterson PR; Beard DJ; Jobling CM; Laufer S; Munt PL; Tries S
Arzneimittelforschung; 1995 Feb; 45(2):159-65. PubMed ID: 7710439
[TBL] [Abstract][Full Text] [Related]
18. Mutagenicity studies of benzalazine.
Herzog R; Leuschner J
Arzneimittelforschung; 1994 Dec; 44(12):1366-8. PubMed ID: 7848359
[TBL] [Abstract][Full Text] [Related]
19. Distribution and excretion of [14C]-labelled [2,2-dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizine-5- yl]- [2'-14C]-acetic acid in rats.
Deigner HP; Freyberg CE; Laufer S
Arzneimittelforschung; 1995 Mar; 45(3):272-6. PubMed ID: 7741783
[TBL] [Abstract][Full Text] [Related]
20. Genotoxicity studies on a high-purity rebaudioside A preparation.
Williams LD; Burdock GA
Food Chem Toxicol; 2009 Aug; 47(8):1831-6. PubMed ID: 19427890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
